Nomura Holdings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-32,900
Closed -$2.87M 1918
2025
Q2
$2.87M Buy
+32,900
New +$2.58M 0.01% 735
2024
Q3
Sell
-17,500
Closed -$1.98M 1645
2024
Q2
$1.98M Sell
17,500
-288,500
-94% -$36.5M ﹤0.01% 947
2024
Q1
$42.4M Buy
+306,000
New +$38.5M 0.11% 140
2023
Q3
Sell
-69,300
Closed -$8.91M 1445
2023
Q2
$8.91M Sell
69,300
-68,300
-50% -$8.26M 0.02% 365
2023
Q1
$16M Buy
+137,600
New +$15.4M 0.05% 237
2022
Q4
Sell
-117,500
Closed -$9.46M 1549
2022
Q3
$9.46M Buy
117,500
+77,700
+195% +$6.58M 0.04% 365
2022
Q2
$3.09M Buy
+39,800
New +$3.63M 0.01% 677
2022
Q1
Sell
-331,600
Closed -$44.6M 2065
2021
Q4
$44.6M Buy
331,600
+167,600
+102% +$24.1M 0.11% 132
2021
Q3
$22.5M Buy
+164,000
New +$20.7M 0.06% 200
2021
Q2
Sell
-27,600
Closed -$2.48M 2091
2021
Q1
$2.48M Buy
+27,600
New +$2.59M 0.01% 776

Other funds holding DXCM

Nomura Holdings's DXCM Position: Q1 2026 in Review

Nomura Holdings increased its DexCom (DXCM) stake by 355% in Q1 2026, buying an estimated $15.5M and bringing the position to 285,040 shares worth $17.9M. The position accounts for 0.05% of the portfolio, ranked #273.

Nomura Holdings first reported a position in DXCM in Q2 2013 and has held it in 35 quarters since. The position peaked at $22.3M in Q4 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Nomura Holdings held 285,040 shares of DexCom worth $17.9M as of Q1 2026.
  • Nomura Holdings bought 222,325 DexCom shares in Q1 2026, an estimated $15.5M.
  • DexCom made up 0.05% of Nomura Holdings's portfolio in Q1 2026, its #273 holding.
  • Nomura Holdings first reported a position in DexCom in Q2 2013 and has held it in 35 quarters since.
  • Nomura Holdings's DexCom position peaked at $22.3M in Q4 2021.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.